- Home
- OPK
OPK
OPKO Health Inc.
as 11-24-2025 10:59am EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 1.1B | IPO Year: | 1995 |
| Target Price: | $2.28 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.11 - $2.04 | Next Earning Date: | 10-29-2025 |
| Revenue: | $642,067,000 | Revenue Growth: | -9.75% |
| Revenue Growth (this year): | -15.22% | Revenue Growth (next year): | -4.81% |
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 21 '25 | Buy | $1.32 | 580,000 | $768,807.41 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 20 '25 | Buy | $1.34 | 580,000 | $771,327.70 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 19 '25 | Buy | $1.30 | 580,000 | $759,115.40 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 18 '25 | Buy | $1.27 | 533,300 | $678,905.83 | 216,513,578 |
Latest OPKO Health Inc. News
OPK Breaking Stock News: Dive into OPK Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade
The Fly
4 days ago
Astera initiated, Nasdaq upgraded: Wall Street's top analyst calls
Simply Wall St.
4 days ago
OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla
MT Newswires
5 days ago
Update: Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing
MT Newswires
5 days ago
Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing
GlobeNewswire
5 days ago
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
MT Newswires
5 days ago
Correction: Opko Health Insider Bought Shares Worth $737,748, According to a Recent SEC Filing
MT Newswires
6 days ago
Opko Health Insider Bought Shares Worth $678,906, According to a Recent SEC Filing
Compare OPK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.